Teaching Responsibility
LJMU Schools involved in Delivery:
Pharmacy & Biomolecular Sciences
Learning Methods
Lecture
Online
Placement
Practical
Seminar
Tutorial
Workshop
Module Offerings
6000IMPHAR-SEP-CTY
Aims
To enable students to critically review and consolidate clinical evidence and patient specific information to optimise care
Learning Outcomes
1.
Demonstrate an evidence-based approach to critically evaluate and optimise the management of health, disease and wellbeing.
2.
Apply knowledge gained from critical evaluation of scientific literature and training in current research methods to evaluate research and clinical guidelines
3.
Apply sound, reasoned and appropriate judgement to professional situations.
4.
Recognise the challenges posed by caring for patients in real world circumstances and develop and apply strategies to overcome them.
5.
Demonstrate appropriate skills, attitude, emerging leadership and team attributes for a future healthcare professional.
Module Content
Outline Syllabus:Personalised Healthcare (Biomarkers of disease, therapeutic drug monitoring, individual needs)
Caring for the Population (Evidence Based Medicine, Formulary development)
Broadening Professional Perspectives
Professional Development
Research
Endocrine disorders,
Mental Health
Musculoskeletal
Oncology
Module Overview:
During this year, you will take the single modality learning of disease and illness from previous levels and transfer this to multi-morbidity long-term conditions, whose treatment relates to wider health and social care provision. As in previous levels, new knowledge will be incorporated into your existing knowledge, augmenting your development of a representative integrative perspective of the programme. For example, the concepts of formulation, drug monitoring, medicines optimisation, adverse drug reactions and toxicity will initially be delivered in the context of topics introduced in previous years, such as cardiovascular and respiratory systems. These concepts will then be applied to the endocrine system, mental health, musculoskeletal disorders, and oncology topics. The balance between evidence-based medicine and personalised treatment will be further explored both at the level of the individuals health and that of the public. Professional development will be firmly embedded into your learning with increasingly complex clinical skills being immersed in the range of multi-morbidity long-term conditions. You will continue to progress the development of your research skills with a series of research seminars, including understanding of research philosophy, the underlying tenets of the relevant scientific and social science methodologies inherent in pharmacy.
During this year, you will take the single modality learning of disease and illness from previous levels and transfer this to multi-morbidity long-term conditions, whose treatment relates to wider health and social care provision. As in previous levels, new knowledge will be incorporated into your existing knowledge, augmenting your development of a representative integrative perspective of the programme. For example, the concepts of formulation, drug monitoring, medicines optimisation, adverse drug reactions and toxicity will initially be delivered in the context of topics introduced in previous years, such as cardiovascular and respiratory systems. These concepts will then be applied to the endocrine system, mental health, musculoskeletal disorders, and oncology topics. The balance between evidence-based medicine and personalised treatment will be further explored both at the level of the individuals health and that of the public. Professional development will be firmly embedded into your learning with increasingly complex clinical skills being immersed in the range of multi-morbidity long-term conditions. You will continue to progress the development of your research skills with a series of research seminars, including understanding of research philosophy, the underlying tenets of the relevant scientific and social science methodologies inherent in pharmacy.
Additional Information:This module forms the third year of the integrated masters in Pharmacy.
There is a requirement (agreed variance from the Academic Framework) that all assessment components must be passed at the module pass mark or higher for the module to be passed. No credit will be released unless all competencies (C1-C6) are achieved.